Many times when people are experienced reactions to prescription drugs, they often wonder if the medication they are taking has been the subject of complaints and lawsuits.
While there is potential for injury with any prescription drug, there are certain drugs that have been shown to be especially harmful, and which have been the subject of class-action lawsuits. These are the drugs we most commonly refer to as “dangerous drugs.” The following is a short list of some of the most well-known defective medications:
- Invokana lawsuit
- And more
Get Legal Help As Soon As Possible
If you or a loved one’s health has been compromised, or worse, because of the adverse reactions to a dangerous prescription drug, you should consult with an experienced injury attorney right was because time is running against you. Often times these drug recalls with be followed by a class action federal lawsuit (multi-district litigation). Many times there is a pool of money set aside for victims. The earlier you can get to the funds, the more likely you are to get a fair settlement. Many times people who wait get very little or nothing because the settlement fund has been exhausted.
Don’t wait to find out what your options are. If you’ve been injured by a bad prescription drug, you can talk to one of our injury attorneys for FREE. Call us today at (210) 910-4357 to learn what to do to protect your rights, your health, and your financial future.
If You Have Questions, We Have Answers!
In all cases, we recommend that you talk to your doctor about any recalled drug that you are taking.
However, with questions about whether or not you have a case, or how to proceed to protect your rights, we have the answers, help, and guidance you need and deserve.
Get Your FREE 5-Point Case Evaluation
We offer injured persons a FREE 5-Point Case Evaluation, which is a written report that helps accident victims understand their case, provides answers to common questions, and gives help and guidance as to what steps should be taken.
To order your FREE report, click here.